J. Timothy Caldwell

949 total citations
18 papers, 578 citations indexed

About

J. Timothy Caldwell is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. Timothy Caldwell has authored 18 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. Timothy Caldwell's work include Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). J. Timothy Caldwell is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Protein Degradation and Inhibitors (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). J. Timothy Caldwell collaborates with scholars based in United States, China and Australia. J. Timothy Caldwell's co-authors include Yubin Ge, Jeffrey W. Taub, Holly Edwards, Chengzhi Xie, Guan Wang, Steven Buck, Hai Lin, Xiaojia Niu, Roland Chu and Jianyun Zhao and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

J. Timothy Caldwell

17 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Timothy Caldwell United States 13 376 251 114 83 57 18 578
Yasukazu Kawai Japan 11 253 0.7× 194 0.8× 78 0.7× 77 0.9× 55 1.0× 38 487
Jieyu Ye China 14 190 0.5× 375 1.5× 154 1.4× 128 1.5× 70 1.2× 49 695
Mohamed Elhamri France 14 181 0.5× 323 1.3× 159 1.4× 114 1.4× 36 0.6× 44 507
Matthew A. Kutny United States 11 259 0.7× 320 1.3× 90 0.8× 157 1.9× 43 0.8× 39 487
Audrey Sarry France 12 152 0.4× 410 1.6× 103 0.9× 103 1.2× 15 0.3× 27 514
Jonathan M. Keller United States 11 262 0.7× 155 0.6× 117 1.0× 18 0.2× 54 0.9× 22 610
Jagoda Jasielec United States 13 339 0.9× 390 1.6× 252 2.2× 41 0.5× 10 0.2× 40 553
Monique Steijaert Netherlands 12 179 0.5× 281 1.1× 285 2.5× 62 0.7× 29 0.5× 13 615
DJ Roe United States 6 208 0.6× 142 0.6× 321 2.8× 50 0.6× 20 0.4× 11 564
Sarah S. Burns United States 15 167 0.4× 72 0.3× 85 0.7× 22 0.3× 128 2.2× 28 468

Countries citing papers authored by J. Timothy Caldwell

Since Specialization
Citations

This map shows the geographic impact of J. Timothy Caldwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Timothy Caldwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Timothy Caldwell more than expected).

Fields of papers citing papers by J. Timothy Caldwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Timothy Caldwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Timothy Caldwell. The network helps show where J. Timothy Caldwell may publish in the future.

Co-authorship network of co-authors of J. Timothy Caldwell

This figure shows the co-authorship network connecting the top 25 collaborators of J. Timothy Caldwell. A scholar is included among the top collaborators of J. Timothy Caldwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Timothy Caldwell. J. Timothy Caldwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hutchinson, Mark R., Melissa Damschroder, Valentin Stanev, et al.. (2025). Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning. mAbs. 17(1). 2483944–2483944. 4 indexed citations
2.
Sundqvist, Monika, et al.. (2025). Predicting human subcutaneous bioavailability of monoclonal antibodies using an integrated in-vitro/in-silico approach. Journal of Controlled Release. 380. 715–724. 4 indexed citations
3.
Shi, Tiffany, Ashley R. Burg, J. Timothy Caldwell, et al.. (2023). Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality. Journal of Clinical Investigation. 133(14). 22 indexed citations
4.
Girdwood, Sonya Tang, Denise Hasson, J. Timothy Caldwell, et al.. (2022). Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury. Journal of Antimicrobial Chemotherapy. 78(2). 478–487. 13 indexed citations
5.
Wong, Hector R., J. Timothy Caldwell, Natalie Z. Cvijanovich, et al.. (2019). Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Science Translational Medicine. 11(518). 44 indexed citations
6.
Girdwood, Sonya Tang, Stephanie Davis, J. Timothy Caldwell, et al.. (2018). Reducing Electrolyte Testing in Hospitalized Children by Using Quality Improvement Methods. PEDIATRICS. 141(5). 21 indexed citations
7.
Niu, Xiaojia, Jianyun Zhao, Jun Ma, et al.. (2016). Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. Clinical Cancer Research. 22(17). 4440–4451. 181 indexed citations
8.
Edwards, Holly, Alan A. Dombkowski, J. Timothy Caldwell, et al.. (2016). Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia. PLoS ONE. 11(8). e0161539–e0161539. 7 indexed citations
9.
Mathur, Ambika, et al.. (2016). Effect of Music Interventions on Sedation in Children Undergoing Magnetic Resonance Imaging: Clinical Trial. International Journal of Child Health and Nutrition. 5(2). 63–74. 1 indexed citations
11.
Qi, Wenxiu, Chengzhi Xie, J. Timothy Caldwell, et al.. (2014). CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells. Journal of Hematology & Oncology. 7(1). 53–53. 41 indexed citations
12.
Wang, Guan, Xiaojia Niu, Wenbo Zhang, et al.. (2014). Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer. Cancer Letters. 356(2). 656–668. 33 indexed citations
13.
Caldwell, J. Timothy, Yubin Ge, & Jeffrey W. Taub. (2014). Prognosis and management of acute myeloid leukemia in patients with Down syndrome. Expert Review of Hematology. 7(6). 831–840. 23 indexed citations
14.
Xie, Chengzhi, Holly Edwards, J. Timothy Caldwell, et al.. (2014). Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage. Molecular Oncology. 9(2). 409–421. 27 indexed citations
15.
Caldwell, J. Timothy, Holly Edwards, Steven Buck, Yubin Ge, & Jeffrey W. Taub. (2014). Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia. Pediatric Blood & Cancer. 61(10). 1767–1773. 25 indexed citations
16.
Caldwell, J. Timothy, Holly Edwards, Alan A. Dombkowski, et al.. (2013). Overexpression of GATA1 Confers Resistance to Chemotherapy in Acute Megakaryocytic Leukemia. PLoS ONE. 8(7). e68601–e68601. 17 indexed citations
17.
Xie, Chengzhi, Christina D. Drenberg, Holly Edwards, et al.. (2013). Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51. PLoS ONE. 8(11). e79106–e79106. 80 indexed citations
18.
Wang, Guan, Holly Edwards, J. Timothy Caldwell, et al.. (2013). Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells. PLoS ONE. 8(9). e76662–e76662. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026